James E. Goldschmidt
Corporate Officer/Principal at CASI PHARMACEUTICALS, INC.
Profile
Dr. James E.
Goldschmidt is a Chief Business Development Officer at CASI Pharmaceuticals, Inc. and a President-United States at Sandoz, Inc. Dr. Goldschmidt was previously employed as a Senior Vice President-Business Development by CASI Pharmaceuticals, Inc. /Old/, a Chief Operating Officer by Macrophage Therapeutics, Inc., a Vice President-Business Development by ImmuneXcite, Inc., a Vice President-Business & Commercial Development by TetraLogic Pharmaceuticals Corp., an Executive Director-Oncology New Business by Wyeth Pharmaceuticals LLC, a Product Director by GSK Plc, and an Executive Director-Business Development by Johnson & Johnson.
He received his undergraduate degree from Villanova University, a graduate degree from Drexel University and a doctorate degree from Temple University School of Medicine.
James E. Goldschmidt active positions
| Companies | Position | Start |
|---|---|---|
| CASI PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2016-03-31 |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Corporate Officer/Principal | - |
Former positions of James E. Goldschmidt
| Companies | Position | End |
|---|---|---|
Macrophage Therapeutics, Inc.
 Macrophage Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Navidea Biopharmaceuticals, Inc., Macrophage Therapeutics, Inc. develops immune-oncology and anti-inflammatory therapeutics. The CEO of the American company is Mike M. Goldberg. | Chief Operating Officer | 2016-02-29 |
ImmuneXcite, Inc.
 ImmuneXcite, Inc. Pharmaceuticals: MajorHealth Technology ImmuneXcite, Inc. operates as a biopharmaceutical company which develops monoclonal antibodies for cancer. The firm provides nivel immuno-incology technology platform, which leverages both the innate and adaptive immune responses to selectively treat a wide range of tumor types. The company was Ifat Rubin-Bejerano, Gerald R. Fink and Yaniv Bejerano and is headquartered in Waltham, MA. | Corporate Officer/Principal | 2014-12-31 |
| TETRALOGIC PHARMACEUTICALS CORPORATION | Investor Relations Contact | 2012-12-31 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Corporate Officer/Principal | 2003-12-31 |
Training of James E. Goldschmidt
| Drexel University | Graduate Degree |
| Villanova University | Undergraduate Degree |
| Temple University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| TETRALOGIC PHARMACEUTICALS CORPORATION | Health Technology |
| GSK PLC | Health Technology |
| CASI PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 5 |
|---|---|
CASI Pharmaceuticals, Inc. /Old/
 CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Health Technology |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Health Technology |
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Health Technology |
ImmuneXcite, Inc.
ImmuneXcite, Inc. Pharmaceuticals: MajorHealth Technology ImmuneXcite, Inc. operates as a biopharmaceutical company which develops monoclonal antibodies for cancer. The firm provides nivel immuno-incology technology platform, which leverages both the innate and adaptive immune responses to selectively treat a wide range of tumor types. The company was Ifat Rubin-Bejerano, Gerald R. Fink and Yaniv Bejerano and is headquartered in Waltham, MA. | Health Technology |
Macrophage Therapeutics, Inc.
Macrophage Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Navidea Biopharmaceuticals, Inc., Macrophage Therapeutics, Inc. develops immune-oncology and anti-inflammatory therapeutics. The CEO of the American company is Mike M. Goldberg. | Commercial Services |
- Stock Market
- Insiders
- James E. Goldschmidt
